About
Team
Portfolio
News
Contact
Sustainability (swe)
Funds (swe)
About
Team
Portfolio
News
Contact
Sustainability (swe)
Funds (swe)
Everything
Quanta Dialysis Technologies
Navinci Diagnostics
CytaCoat
Senzime
Collective Minds Radiology
Allurion Technologies
Signifier Medical Technologies
SAGA Dx
SMA
2024-11-18
Quanta Dialysis Secures New Funding
2024-11-04
Quanta Dialysis Technologies Receives FDA Clearance for Home Dialysis System
2024-10-24
Jenny Sundqvist appointed CEO of Navinci
2024-09-06
CytaCoat and Absorbest announce development and licensing agreement for superabsorbent advanced wound care dressings
2023-09-28
Segulah Medical Acceleration announces investment in Senzime
2023-08-28
Collective Minds Radiology announces closing of SEK 84m financing, led by Segulah Medical Acceleration and existing shareholders
2023-02-20
Navinci appoints Eva Pisa as chairman, further strengthens the leadership team and establishes a Scientific Advisory Board
2023-02-16
Allurion to Go Public on NYSE
2022-09-13
Segulah Medical Acceleration Announces Investment in Allurion Technologies
2022-07-12
Segulah Medical Acceleration Announces Investment in Navinci Diagnostics
2022-02-28
Signifier Medical Technologies is granted HCPCS Codes
2021-07-30
Segulah Medical Acceleration Announces Investment in Signifier Medical Technologies
2021-06-30
Segulah Medical Acceleration Announces Investment in SAGA Diagnostics
2021-06-28
Segulah Medical Acceleration Announces Investment in Quanta Dialysis Technologies
2021-04-29
Blue chip investors back new MedTech investment company